Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Accelerate Diagnostics Inc (NASDAQ:AXDX)

28.05
Delayed Data
As of 11:37am ET
 -0.45 / -1.58%
Today’s Change
13.65
Today|||52-Week Range
30.45
+35.18%
Year-to-Date
Medtronic (MDT) Partners with Aetna for Type 1 & 2 Diabetes
11:03am / Zacks.com - Paid Partner Content
ConforMIS (CFMS) Gets FDA Approval for iTotal Hip System
Jun 26 / Zacks.com - Paid Partner Content
Thermo Fisher Gets FDA's PMA for Oncomine Dx Target Test
11:03am / Zacks.com - Paid Partner Content
Why Investors Should Buy Align Technology (ALGN) Right Now
Jun 23 / Zacks.com - Paid Partner Content
Penumbra (PEN) at 52-Week High: What's Driving the Stock?
10:08am / Zacks.com - Paid Partner Content
Cooper Companies (COO) Hits 52-Week High on Solid Prospects
Jun 23 / Zacks.com - Paid Partner Content
3 Reasons Why Accelerate Diagnostics (AXDX) is a Great Momentum Stock
9:18am / Zacks.com - Paid Partner Content
Bio-Rad (BIO) Scores a Strong Buy Right Now: Here's How
Jun 22 / Zacks.com - Paid Partner Content
Quest Diagnostics Enhances Blueprint for Athletes Service
Jun 26 / Zacks.com - Paid Partner Content
Here's Why Henry Schein is Worth Adding to Your Portfolio
Jun 22 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close28.50
Today’s open28.50
Day’s range27.60 - 28.67
Volume178,700
Average volume (3 months)326,889
Market cap$1.6B
Dividend yield--
Data as of 11:37am ET, 06/27/2017

Growth & Valuation

Earnings growth (last year)-27.72%
Earnings growth (this year)+8.27%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+67.35%
P/E ratioNM
Price/Sales4,325.11
Price/Book18.87

Competitors

 Today’s
change
Today’s
% change
BIOBBio Rad Laboratories...0.000.00%
PACBPacific Biosciences ...-0.01-0.28%
HBIOHarvard Bioscience I...-0.08-2.88%
ROKARoka Bioscience Inc+0.03+1.15%
Data as of 11:37am ET, 06/27/2017

Financials

Next reporting dateAugust 7, 2017
EPS forecast (this quarter)-$0.30
Annual revenue (last year)$246.0K
Annual profit (last year)-$66.4M
Net profit margin-26,981.30%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Lawrence L. Mehren
Head-
Operations
Kurt Reinhardt
Corporate headquarters
Tucson, Arizona

Forecasts